Literature DB >> 21499277

Should prostate-specific antigen velocity be abandoned?

Stacy Loeb1, H Ballentine Carter.   

Abstract

Entities:  

Year:  2011        PMID： 21499277      PMCID： PMC3739355          DOI： 10.1038/aja.2011.34

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  8 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

2.  Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.

Authors:  Anthony V D'Amico; Andrew A Renshaw; Brenda Sussman; Ming-Hui Chen
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

3.  An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Authors:  Andrew J Vickers; Cathee Till; Catherine M Tangen; Hans Lilja; Ian M Thompson
Journal:  J Natl Cancer Inst       Date:  2011-02-24       Impact factor: 13.506

4.  Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.

Authors:  Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Anna Kettermann; Luigi Ferrucci; E Jeffrey Metter
Journal:  Urology       Date:  2011-01       Impact factor: 2.649

5.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Authors:  H Ballentine Carter; Luigi Ferrucci; Anna Kettermann; Patricia Landis; E James Wright; Jonathan I Epstein; Bruce J Trock; E Jeffrey Metter
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

6.  Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

7.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

Authors:  H B Carter; J D Pearson; E J Metter; L J Brant; D W Chan; R Andres; J L Fozard; P C Walsh
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

8.  Is the utility of prostate-specific antigen velocity for prostate cancer detection affected by age?

Authors:  Stacy Loeb; Kimberly A Roehl; William J Catalona; Robert B Nadler
Journal:  BJU Int       Date:  2008-04       Impact factor: 5.588
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.